Cambridge Investment Group
1776 Pleasant Plain Road, Fairfield, IA, 52556-8757, United States
Overview
Cambridge Investment Research is a financial solutions firm focused on serving independent financial professionals and their investing clients. It offers a broad range of choices for independent financial professionals regarding solutions for advice, growth, technology, and independence. Cambridge’s national reach includes Cambridge Investment Research Advisors – a large corporate RIA; and Cambridge Investment Research – an independent broker-dealer, member FINRA/SIPC, that is among the largest privately-controlled independent broker-dealers in the country. It was founded in 1981 and is headquartered in Fairfield, Iowa.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 9
Sector focus
- Banking
- Finance
- Financial Services
Investment portfolio
- OnLume
Led · Series A · Apr 2021
OnLume Surgical develops novel fluorescence-guided surgery (FGS) imaging systems for use during a range of surgical procedures. Its core product is an FDA-cleared FGS imaging system for fluorescence imaging of blood flow and tissue perfusion before, during and after vascular, gastrointestinal, organ transplant, plastic, reconstructive and microsurgeries. The system is designed to illuminate critical anatomy in real time to optimize precision, improve patient outcomes, reduce morbidity and lower costs. OnLume is also developing additional applications of its imaging platform, including tumor-specific fluorescent agents to help surgeons identify residual cancer tissue. Financially, the company completed a Series A financing raising over $7 million and previously received a $2 million Phase II SBIR grant from the National Cancer Institute. Proceeds are intended to support a commercial launch into its first market vertical and to advance other market opportunities over the next 24 months.